Artelo Biosciences Inc (NASDAQ: ARTL) is 12.26% higher on its value in year-to-date trading and has touched a low of $0.91 and a high of $1.75 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ARTL stock was last observed hovering at around $1.39 in the last trading session, with the day’s loss setting it -0.2%.
Currently trading at $1.19, the stock is -4.68% and 3.32% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.14 million and changing -14.39% at the moment leaves the stock -3.48% off its SMA200. ARTL registered -19.59% loss for a year compared to 6-month loss of -9.85%. The firm has a 50-day simple moving average (SMA 50) of $1.15176 and a 200-day simple moving average (SMA200) of $1.232865.
The stock witnessed a 2.59% gain in the last 1 month and extending the period to 3 months gives it a 1.71%, and is -10.53% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.13% over the week and 6.25% over the month.
Artelo Biosciences Inc (ARTL) has around 6 employees, a market worth around $3.84M and $0.00M in sales. Distance from 52-week low is 30.77% and -32.00% from its 52-week high. The company has generated returns on investments over the last 12 months (-141.65%).
The EPS is expected to grow by 37.26% this year.
Artelo Biosciences Inc (ARTL) Top Institutional Holders
6.0 institutions hold shares in Artelo Biosciences Inc (ARTL), with institutional investors hold 1.08% of the company’s shares. The shares outstanding are 3.23M, and float is at 3.20M with Short Float at 0.27%. Institutions hold 1.07% of the Float.
Artelo Biosciences Inc (ARTL) Insider Activity
#####
